Patents by Inventor Chris Goodnow

Chris Goodnow has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of screening for B cell activity modulators
    Publication number: 20050169841
    Abstract: The invention provides for the identification of all genes, whether known or novel, which are differentially expressed within and among B cells, making possible the characterization of their temporal regulation and function in the B cell response and/or in B cell mediated disorders. Expression profiles, nucleic acids and proteins are provided for differing states of B cells, including resting, naïve, activated, tolerant and immunosuppressed B cells. The present invention makes possible the identification and characterization of targets useful in prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of immune system disorders.
    Type: Application
    Filed: March 22, 2005
    Publication date: August 4, 2005
    Applicants: Board of Trustees of the Leland Stanford Junior University, Affymetrix, Inc.
    Inventors: Richard Glynne, Chris Goodnow, David Mack
  • Methods of screening for B cell activity modulators
    Patent number: 6913882
    Abstract: The invention provides for the identification of all genes, whether known or novel, which are differentially expressed within and among B cells, making possible the characterization of their temporal regulation and function in the B cell response and/or in B cell mediated disorders. Expression profiles, nucleic acids and proteins are provided for differing states of B cells, including resting, naive, activated, tolerant and immunosuppressed B cells. The present invention makes possible the identification and characterization of targets useful in prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of immune system disorders.
    Type: Grant
    Filed: December 21, 2000
    Date of Patent: July 5, 2005
    Assignees: Affymetrix, Inc., Board of Trustees of the Leland Stanford Junior University
    Inventors: Richard Glynne, Chris Goodnow, David Mack
  • Novel compositions and methods of screening for B cell activity modulators
    Publication number: 20010031462
    Abstract: The invention provides for the identification of all genes, whether known or novel, which are differentially expressed within and among B cells, making possible the characterization of their temporal regulation and function in the B cell response and/or in B cell mediated disorders. Expression profiles, nucleic acids and proteins are provided for differing states of B cells, including resting, naive, activated, tolerant and immunosuppressed B cells. The present invention makes possible the identification and characterization of targets useful in prognosis, diagnosis, monitoring, rational drug design, and/or therapeutic intervention of immune system disorders.
    Type: Application
    Filed: December 21, 2000
    Publication date: October 18, 2001
    Inventors: Richard Glynne, Chris Goodnow, Davis Mack